Memantine Hydrochloride Tablet
Product Images NDC 71610-911

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 71610-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 01)

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 02)

This text provides information on the mean change from baseline in ADCS-ADL score over 12 weeks of treatment, showing both clinical improvement and clinical decline. SEM (Standard Error of the Mean) data may be available as well.*

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 03)

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 04)

This text provides information about the mean change from baseline in SIB score and clinical improvement over weeks of treatment. The data is presented in a simple visual format.*

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 05)

This text provides information about a placebo solution with M HCI concentration levels, including a chart displaying changing values of "BB Chanae fom Beselne". The dataset appears to be related to some sort of scientific or experimental study.*

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 06)

This is a comparison of mean (SEM) change from baseline in ADCS-ADL score between Placebo + Donepezil and MHCIDonepezil over 12 to 14 weeks of treatment.*

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 07)

This information seems to be related to data on the Cumulative Percentage of Patients and the change in ADCS-ADL score from baseline. The text shows the percentage of patients for different treatments as well as the change in the ADCS-ADL score.*

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 08)

FDA Label Image

Memantine Hydrochloride Tablets (2dee57d8 27d7 481c B1c9 21375e258a1b 09)

This text provides information on the cumulative percentage of patients in a study comparing a placebo group to a group administered with donepezil, a drug commonly used for Alzheimer's treatment. It also includes data on the change in the Severe Impairment Battery (SIB) scores from baseline.*

FDA Label Image

Label (71619 0911 60)

FDA Label Image

Aphena (Aphena)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.